KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Other Accumulated Expenses (2018 - 2025)

ClearPoint Neuro's Other Accumulated Expenses history spans 13 years, with the latest figure at $1.7 million for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses rose 48.64% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $1.7 million, up 48.64%, while the annual FY2024 figure was $1.4 million, 37.7% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $1.7 million at ClearPoint Neuro, up from $1.2 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.1 million in Q4 2022 and bottomed at $473000.0 in Q1 2021.
  • The 5-year median for Other Accumulated Expenses is $1.2 million (2024), against an average of $1.2 million.
  • The largest annual shift saw Other Accumulated Expenses skyrocketed 284.54% in 2022 before it plummeted 49.01% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $537000.0 in 2021, then surged by 284.54% to $2.1 million in 2022, then plummeted by 49.01% to $1.1 million in 2023, then skyrocketed by 37.7% to $1.4 million in 2024, then rose by 20.55% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Other Accumulated Expenses are $1.7 million (Q3 2025), $1.2 million (Q2 2025), and $1.5 million (Q1 2025).